{"id":"W4416974763","doi":"10.12809/hkmj2513054","title":"Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Hong Kong Medical Journal","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Breast cancer; Perioperative; Neoadjuvant therapy; Chemotherapy; Mastectomy; Clinical trial; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004393011,0.0001416681,0.0002442122,0.00004240453,0.0002437598,0.00002891697,0.0002049176,0.0001485715,0.000125802],"category_scores_gemma":[0.001556278,0.00008896284,0.0002159218,0.00009367286,0.0003520591,0.000004133983,0.00007814149,0.0002864266,0.000001474767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004445506,"about_ca_system_score_gemma":0.0004962445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001059839,"about_ca_topic_score_gemma":0.0001015884,"domain_scores_codex":[0.99862,0.000241444,0.0004623761,0.0002190283,0.0002399071,0.0002172503],"domain_scores_gemma":[0.9983723,0.0008262958,0.0001969194,0.0002030189,0.0002722795,0.0001292043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.005708373,0.0009329271,0.07913589,0.00002816871,0.003010483,0.00002090484,0.000350513,0.00001632107,0.001396604,0.0009683669,0.6975631,0.2108684],"study_design_scores_gemma":[0.01506163,0.0008694454,0.8891242,0.001201664,0.0003659386,0.0002981052,0.0009791828,0.0001844397,0.006748594,0.0008107723,0.08390997,0.0004460861],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8598347,0.0008919666,0.003143041,0.1323813,0.002329853,0.0004960886,0.0004373491,0.00001374795,0.0004720159],"genre_scores_gemma":[0.9918306,0.001878375,0.0008076287,0.003999545,0.000835199,0.00008544366,0.00001602125,0.00001643115,0.0005307702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8099883,"threshold_uncertainty_score":0.3627799,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05384642136366831,"score_gpt":0.3802367739213978,"score_spread":0.3263903525577295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}